A clinical-stage biotech company based in Los Altos, California, developing treatments for kidney diseases.

A clinical-stage biotech company developing therapies that modulate the innate immune system to treat neurodegenerative ...

US biopharma Syntis Bio, which is developing oral therapies for obesity, diabetes and rare diseases, has announced the close ...

Swiss biopharma company BioVersys (today announced a research and exclusive license option agreement with the Japanese ...

Australian neurodegenerative diseases specialist Neurizon Therapeutics has agreed an exclusive global license agreement with ...

A federal judge has blocked the US Department of Health and Human Services from moving forward with a major workforce ...

Hungarian drugmaker Gedeon Richter has announced that the European Commission has granted marketing authorization for the biosimilar denosumab products Junod and Yaxwer.

Under the terms of the deal, HanchorBio will receive an upfront payment of $10 million, with additional payments tied to ...

US pharma giant Merck & Co today revealed that the US Food and Drug Administration (FDA) has accepted and granted priority ...

Alnylam Pharmaceuticals (Nasdaq: ALNY) has won European Commission approval for Amvuttra (vutrisiran) to treat transthyretin ...

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...

Mitsubishi Tanabe Pharma Corporation is now under the ownership of US private investment firm Bain Capital Private Equity.